{"id":"https://openalex.org/W2913802458","doi":"https://doi.org/10.1080/2162402x.2018.1564505","title":"Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients","display_name":"Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients","publication_year":2019,"publication_date":"2019-01-22","ids":{"openalex":"https://openalex.org/W2913802458","doi":"https://doi.org/10.1080/2162402x.2018.1564505","mag":"2913802458","pmid":"https://pubmed.ncbi.nlm.nih.gov/30906658","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6422400"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2018.1564505","doi":"https://doi.org/10.1080/2162402x.2018.1564505","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1564505","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1564505?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1564505?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018585640","display_name":"Emeric Limagne","orcid":"https://orcid.org/0000-0002-1098-8441","observed_orcids":["https://orcid.org/0000-0002-1098-8441"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emeric Limagne","raw_affiliation_strings":["Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010144431","display_name":"Corentin Richard","orcid":"https://orcid.org/0000-0001-9732-0219","observed_orcids":["https://orcid.org/0000-0001-9732-0219"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Corentin Richard","raw_affiliation_strings":["Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","Univ. Bourgogne Franche-Comt\u00e9, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":["https://openalex.org/I4210118524"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085250039","display_name":"Marion Thibaudin","orcid":"https://orcid.org/0000-0002-1046-5982","observed_orcids":["https://orcid.org/0000-0002-1046-5982"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marion Thibaudin","raw_affiliation_strings":["Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016814827","display_name":"Jean-David Fumet","orcid":"https://orcid.org/0000-0002-9444-941X","observed_orcids":["https://orcid.org/0000-0002-9444-941X"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-David Fumet","raw_affiliation_strings":["Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011315376","display_name":"Caroline Truntzer","orcid":"https://orcid.org/0000-0003-0895-4813","observed_orcids":["https://orcid.org/0000-0003-0895-4813"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Truntzer","raw_affiliation_strings":["Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110475951","display_name":"Aur\u00e9lie Lagrange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Aur\u00e9lie Lagrange","raw_affiliation_strings":["Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111542346","display_name":"Laure Favier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laure Favier","raw_affiliation_strings":["Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028309188","display_name":"Bruno P. Coudert","orcid":"https://orcid.org/0000-0001-9445-2216","observed_orcids":["https://orcid.org/0000-0001-9445-2216"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bruno Coudert","raw_affiliation_strings":["Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210118524","display_name":"Universit\u00e9 Bourgogne Franche-Comt\u00e9","ror":"https://ror.org/02dn7x778","country_code":"FR","type":"education","lineage":["https://openalex.org/I4210118524"]},{"id":"https://openalex.org/I4210139033","display_name":"Centre de recherche Translationnelle en M\u00e9decine mol\u00e9culaire","ror":"https://ror.org/04d70nb60","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I159885104","https://openalex.org/I2746051580","https://openalex.org/I4210117091","https://openalex.org/I4210135996","https://openalex.org/I4210139033","https://openalex.org/I4399657933","https://openalex.org/I4405253280"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Fran\u00e7ois Ghiringhelli","raw_affiliation_strings":["Centre de Recherche INSERM LNC-UMR1231, Dijon, France","Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France","Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","Univ. Bourgogne Franche-Comt\u00e9, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche INSERM LNC-UMR1231, Dijon, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210139033"]},{"raw_affiliation_string":"Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"Platform of Transfer in Cancer Biology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"Univ. Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":["https://openalex.org/I4210118524"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5043463827"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210094685","https://openalex.org/I4210118524","https://openalex.org/I4210139033"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":11.3452,"has_fulltext":false,"cited_by_count":211,"citation_normalized_percentile":{"value":0.99047593,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"8","issue":"4","first_page":"e1564505","last_page":"e1564505"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monocytic-myeloid-derived-suppressor-cells","display_name":"monocytic myeloid-derived suppressor cells","score":0.9380000233650208},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.8980000019073486},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9620000123977661},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/primary-resistance","display_name":"primary resistance","score":0.6990000009536743},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.7990000247955322},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/anti-tim-3-antibody","display_name":"anti-TIM-3 antibody","score":0.7129999995231628},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8121219873428345},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7849293947219849},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5758167505264282},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5642217993736267},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5131943821907043},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4899872839450836},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4471368193626404},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.44288215041160583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4284977614879608},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42324405908584595},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.4148534834384918},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4139198958873749},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4001975357532501},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1080/2162402x.2018.1564505","doi":"https://doi.org/10.1080/2162402x.2018.1564505","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1564505","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1564505?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5411892","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6422400","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6422400","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6422400","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmid:30906658","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30906658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6e7ef7f788ca47dcb154282961fad625","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6e7ef7f788ca47dcb154282961fad625","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoImmunology, Vol 8, Iss 4 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2018.1564505","doi":"https://doi.org/10.1080/2162402x.2018.1564505","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2018.1564505","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1564505?needAccess=true","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2913802458.pdf"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1965031244","https://openalex.org/W1965215390","https://openalex.org/W1967084952","https://openalex.org/W1969814796","https://openalex.org/W1982488143","https://openalex.org/W1986533011","https://openalex.org/W2010597200","https://openalex.org/W2076956606","https://openalex.org/W2104347254","https://openalex.org/W2106787323","https://openalex.org/W2107863654","https://openalex.org/W2109485845","https://openalex.org/W2135707184","https://openalex.org/W2152649567","https://openalex.org/W2198093519","https://openalex.org/W2270932386","https://openalex.org/W2282962877","https://openalex.org/W2344013086","https://openalex.org/W2397854274","https://openalex.org/W2482957815","https://openalex.org/W2504822853","https://openalex.org/W2527905628","https://openalex.org/W2562305489","https://openalex.org/W2589148013","https://openalex.org/W2596185898","https://openalex.org/W2601943254","https://openalex.org/W2605630275","https://openalex.org/W2606711458","https://openalex.org/W2607288266","https://openalex.org/W2736006101","https://openalex.org/W2782007611","https://openalex.org/W2795636496","https://openalex.org/W2808333550","https://openalex.org/W2917837889","https://openalex.org/W4251594795","https://openalex.org/W4251687953"],"related_works":["https://openalex.org/W2787949310","https://openalex.org/W4401512288","https://openalex.org/W2912691281","https://openalex.org/W3200165923","https://openalex.org/W4401794413","https://openalex.org/W2767799231","https://openalex.org/W6969113249","https://openalex.org/W4404064212","https://openalex.org/W4388047636","https://openalex.org/W4224078757"],"abstract_inverted_index":{"Nivolumab,":[0],"a":[1,24,53,188],"monoclonal":[2],"antibody":[3,143],"targeting":[4],"PD-1,":[5],"is":[6,40,121],"currently":[7],"approved":[8],"for":[9,44,129,191],"metastatic":[10],"non-small":[11],"cell":[12],"lung":[13,151],"cancer":[14,152],"(mNSCLC)":[15],"treatment":[16],"after":[17,84],"failure":[18],"of":[19,26,47,56,89,97,109,157,178],"first-line":[20],"chemotherapy.":[21],"However,":[22],"only":[23],"quarter":[25],"patients":[27,130,153],"benefit":[28],"from":[29,150],"this":[30,37],"therapy":[31],"with":[32,66,131],"objective":[33],"clinical":[34],"response.":[35],"In":[36,139],"context,":[38],"there":[39],"an":[41],"unmet":[42],"need":[43],"improved":[45],"understanding":[46],"resistance":[48,124,136,145,182],"mechanisms.":[49],"Thus,":[50],"we":[51,105],"studied":[52],"prospective":[54],"cohort":[55],"mNSCLC":[57],"(n":[58],"=":[59],"61)":[60],"treated":[61],"in":[62,123,148],"second":[63],"or":[64,133,180],"third-line":[65],"nivolumab.":[67],"We":[68],"analyzed":[69],"various":[70],"blood":[71,158],"myeloid":[72,100],"and":[73,83,86,102,112,119,154,173,185],"lymphoid":[74,110],"markers":[75],"by":[76],"flow":[77],"cytometry":[78],"(176":[79],"variables)":[80],"at":[81],"baseline,":[82],"15":[85],"30":[87],"days":[88],"therapy.":[90],"By":[91],"attempting":[92],"to":[93,125,137,146,183],"link":[94],"the":[95,170],"evolution":[96],"peripheral":[98],"lymphoid,":[99],"cells":[101,111],"anti-PD-1":[103,147,163,184],"response,":[104],"observed":[106],"that":[107,169],"accumulation":[108],"monocytic":[113],"MDSC":[114],"(mMDSC)":[115],"expressing,":[116],"respectively,":[117],"Tim-3":[118],"galectin-9":[120],"implicated":[122],"PD-1":[126],"blockade":[127],"both":[128],"primary":[132,179],"acquired":[134],"secondary":[135,181],"anti-PD-1.":[138],"vitro,":[140],"anti-Tim-3":[141],"blocking":[142],"reverses":[144],"PBMC":[149],"high":[155],"levels":[156],"mMDSC":[159,174],"negatively":[160],"impact":[161],"on":[162],"efficacy.":[164],"Together,":[165],"these":[166],"data":[167],"underline":[168],"galectin-9/Tim-3":[171],"pathway":[172],"are":[175],"key":[176],"mechanisms":[177],"could":[186],"be":[187],"new":[189],"target":[190],"immunotherapy":[192],"drug":[193],"combinations.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":14},{"year":2025,"cited_by_count":39},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":30},{"year":2022,"cited_by_count":32},{"year":2021,"cited_by_count":31},{"year":2020,"cited_by_count":32},{"year":2019,"cited_by_count":6},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2019-02-21T00:00:00"}